These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 15506928)

  • 21. Cadherins in Wilms' tumor: E-cadherin expression despite absence of WT1.
    Baudry D; Cabanis MO; Patte C; Zucker JM; Pein F; Fournet JC; Sarnacki S; Junien C; Jeanpierre C
    Anticancer Res; 2003; 23(1A):475-8. PubMed ID: 12680252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Wilms' tumour suppressor WT1 is involved in endothelial cell proliferation and migration: expression in tumour vessels in vivo.
    Wagner N; Michiels JF; Schedl A; Wagner KD
    Oncogene; 2008 Jun; 27(26):3662-72. PubMed ID: 18212735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic utility of Wilms' tumour-1 protein (WT-1) immunostaining in paediatric renal tumours.
    Goyal S; Mishra K; Sarkar U; Sharma S; Kumari A
    Indian J Med Res; 2016 May; 143(Supplement):S59-S67. PubMed ID: 27748279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
    Rivera MN; Haber DA
    Nat Rev Cancer; 2005 Sep; 5(9):699-712. PubMed ID: 16110318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
    Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
    Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function.
    Guan LS; Liu JJ; Xu YH; Wang ZY
    Cancer Res; 1998 Sep; 58(18):4180-4. PubMed ID: 9751632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modelling.
    Kennedy D; Ramsdale T; Mattick J; Little M
    Nat Genet; 1996 Mar; 12(3):329-31. PubMed ID: 8589729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional properties of WT1.
    Haber DA; Englert C; Maheswaran S
    Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transcriptional regulation by WT1 in development.
    Roberts SG
    Curr Opin Genet Dev; 2005 Oct; 15(5):542-7. PubMed ID: 16099645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Wilms' tumor 1 and signal transducers and activators of transcription 3 synergistically promote cell proliferation: a possible mechanism in sporadic Wilms' tumor.
    Rong Y; Cheng L; Ning H; Zou J; Zhang Y; Xu F; Liu L; Chang Z; Fu XY
    Cancer Res; 2006 Aug; 66(16):8049-57. PubMed ID: 16912181
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular and cellular biology of Wilms' tumour.
    Maitland NJ; Brown KW; Poirier V; Shaw AP; Williams J
    Anticancer Res; 1989; 9(5):1417-26. PubMed ID: 2556071
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
    Zhang X; Xing G; Saunders GF
    Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Wnt-4 regulation by the Wilms' tumour suppressor gene, WT1.
    Sim EU; Smith A; Szilagi E; Rae F; Ioannou P; Lindsay MH; Little MH
    Oncogene; 2002 May; 21(19):2948-60. PubMed ID: 12082525
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exclusion of the Wilms tumour gene (WT1) promoter as a site of frequent mutation in Wilms tumour.
    Grubb GR; Yun K; Reeve AE; Eccles MR
    Oncogene; 1995 Apr; 10(8):1677-81. PubMed ID: 7731725
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N; Maor S; Sarfstein R; Abramovitch S; Welshons WV; Curran EM; Lee AV; Werner H
    J Mol Endocrinol; 2005 Aug; 35(1):135-44. PubMed ID: 16087727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vascular biology and the sex of flies: regulation of vascular smooth muscle cell proliferation by wilms' tumor 1-associating protein.
    Small TW; Penalva LO; Pickering JG
    Trends Cardiovasc Med; 2007 Oct; 17(7):230-4. PubMed ID: 17936204
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Midkine as a novel target gene for the Wilms' tumor suppressor gene (WT1).
    Adachi Y; Matsubara S; Pedraza C; Ozawa M; Tsutsui J; Takamatsu H; Noguchi H; Akiyama T; Muramatsu T
    Oncogene; 1996 Nov; 13(10):2197-203. PubMed ID: 8950987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anlaysis of complementary expression profiles following WT1 induction versus repression reveals the cholesterol/fatty acid synthetic pathways as a possible major target of WT1.
    Rae FK; Martinez G; Gillinder KR; Smith A; Shooter G; Forrest AR; Grimmond SM; Little MH
    Oncogene; 2004 Apr; 23(17):3067-79. PubMed ID: 15021918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.